Patents Assigned to VIIV Healthcare Company
  • Publication number: 20130172559
    Abstract: The present invention is to provide a novel compound (I) shown below, having the anti-virus activity, particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug, as well as a process and an intermediate thereof. (wherein Z1 is NR4; R1 is hydrogen or lower alkyl; X is a single bond, a hetero atom group selected from O, S, SO, SO2 and NH, or lower alkylene or lower alkenylene in which the hetero atom group may intervene; R2 is optionally substituted aryl; R3 is hydrogen, a halogen, hydroxy, optionally substituted lower alkyl etc; and R4 and Z2 part taken together forms a ring, to form a polycyclic compound, including e.g., a tricyclic or tetracyclic compound.
    Type: Application
    Filed: February 8, 2013
    Publication date: July 4, 2013
    Applicants: VIIV HEALTHCARE COMPANY, SHIONOGI & CO., LTD.
    Inventors: Shionogi & Co., Ltd., VIIV Healthcare Company
  • Patent number: 8410103
    Abstract: The present invention is directed to a substituted 2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2 -a]pyrido[1,2-d]pyrazine-5,7-dione useful as an anti-HIV agent, which has the formula: as well as pharmaceutically acceptable salts thereof, compostions thereof, and methods of use thereof.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: April 2, 2013
    Assignees: Shionogi & Co., Ltd., VIIV Healthcare Company
    Inventors: Brian Alvin Johns, Takashi Kawasuji, Teruhiko Taishi, Yoshiyuki Taoda